Marie Sjogren
Malmoe, M, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Sulindac prevents increased mitochondrial VDAC1 expression and cell surface mistargeting induced by pathological conditions in retinal cells.
Journal: Biochemical and biophysical research communications
Published: July 19, 2024
Altered Adipocyte Cell Size Distribution Prior to Weight Loss in the R6/2 Model of Huntington's Disease.
Journal: Journal of Huntington's disease
Published: September 18, 2023
The Human Melanoma Proteome Atlas-Complementing the melanoma transcriptome.
Journal: Clinical and translational medicine
Published: March 12, 2021
The human melanoma proteome atlas-Defining the molecular pathology.
Journal: Clinical and translational medicine
Published: March 12, 2021
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease.
Increased intestinal permeability and gut dysbiosis in the R6/2 mouse model of Huntington's disease.
Journal: Scientific reports
Published: December 03, 2019
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.
Journal: Neurobiology of disease
Published: February 17, 2019
Dual Therapy with Liraglutide and Ghrelin Promotes Brain and Peripheral Energy Metabolism in the R6/2 Mouse Model of Huntington's Disease.
Journal: Scientific reports
Published: January 30, 2018
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington's disease.
Journal: Scientific reports
Published: July 06, 2017
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Journal: Scientific reports
Published: July 04, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026